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It	is	accepted	now	that	immune	system	plays	an	impor-
tant	role	in	the	control	of	tumor	growth.	Numerous	experi-
mental	studies	carried	out	in	recent	years	have	revealed	
that	the	character	of	interaction	between	tumor	and	host	
organism	is	much	more	complex	and	multifactorial	than	
it	has	been	postulated	by	the	theory	of	immune	control.	
Among	the	factors	of	such	 interaction	one	may	hypo-
thetically	mention	defensins	—	small	cationic	antimicrobal	
peptides	that	are	the	components	of	innate	immunity.
In	the	last	decade	it	has	been	shown	that	a	number	
of	human	tumors	are	characterized	by	hyperexpression	
or	down-regulation	of	certain	defensin	genes	and	 in	
some	cases	serum	levels	of	defensins	may	serve	as	ad-
ditional	diagnostic	markers	of	neoplastic	process	[1–7].	
However,	it	remains	unknown	yet	what	is	a	functional	role	
of	defensin	expression	in	tumor	cells	—	whether	these	
antimicrobials	may	protect	the	host	from	tumor	develop-
ment	by	killing	tumor	cells,	or	benefit	malignization	and	
metastasis.	It	has	been	revealed	that	defensins	may	exert	
oppositely	directed	influence	on	cultured	cells	dependent	
on	their	local	concentration	[8,	9].	Experiments	carried	
in vitro	demonstrated	that	defensins	may	cause	a	strong	
proliferative	response	in	cultured	cells	 in	a	concentra-
tion-dependent	fashion,	stimulating	cell	proliferation	in	
micromolar	concentration	range	[10]	and	promote	motili-
ty	and	invasiveness	of	cancer	cells	in vitro	[11].	However,	
in	higher	concentrations	defensins	are	usually	cytotoxic	
and	cause	 lysis	of	 tumor	cells	 [8]	or	may	 induce	cell	
death	via	mitochondrial	injury	and	intracellular	signalling	
pathways	[12].	In vivo	conditions	are	more	complicated,	
because	in	tumor	microenvironment	defensins	produced	
by	malignant	cells	or	by	blood	cells	infiltrating	tumor	may	
interact	with	various	cell	receptors	or	be	bound	by	HMW	
proteins	of	blood	plasma.	Up	to	date,	just	few	reports	are	
discussing	possible	local	concentrations	of	defensins	in	
oral	squamous	cell	carcinoma	[13].
To	answer	 the	question	on	 the	potential	 role	of	
defensins	in	cancer	it	 looks	reasonable	to	create	an	
appropriate	model	 system	 to	study	various	effects	
of	defensins	in vitro	and	in vivo.	Such	system	should	
represent	 the	 regulated	expression	of	antimicrobial	
peptide	with	possibility	to	evaluate	the	exact	level	of	
peptide’s	production	per	cell	and	the	one	where	such	
production	may	be	stopped	in	a	given	moment.
In	present	study	we	aimed	to	create	cell	line	with	regu-
lated	expression	of	human	beta-defensin-2	(hBD-2)	on	
the	base	of	human	embryonic	kidney	cells	of	HEK293T	
line	and	evaluate	the	influence	of	endogeneously	pro-
duced	hBD-2	on	its	phenotypic	and	growth	patterns.	
MATERIALS AND METHODS
Cell lines. HEK293T	(human	embryonic	kidney)	
cells	were	purchased	from	the	Europian	Collection	of	
Animal	Cell	Cultures.	Cells	were	cultivated	in	DMEM	
with	high	glucose	content	supplemented	with	10%	fetal	
bovine	serum	(FBS),	100	units/mL	penicillin	G	sodium	
salt,	100	µg/ml	streptomycin	sulfate	and	0.25	µg/ml	
amphotericin	B	as	fungizone.
Gene cloning and plasmid constructions.	The	
genes	for	mature	β-defensin-2	were	cloned	from	total	
RNA	isolated	from	A431	cells	treated	with	1	µg/ml	EGF	[14]	
by	RT-PCR	using	specific	primers.	To	hBD-2m	(mature	
molecule):	forward	—	5´-ACT-TAA-GCT-TGC-CAT-GGG-
TAT-AGG-CGA-TCC-TGT-TAC-3´,	and	reverse	—	5´-TCT-
TGG-AAT-TCT-CAT-GGC-TTT-TTG-CAG-CATTTT-G-3´)	
(GenBank	accession	no.	AF040153).	PCR	products	were	
digested	with	HindIII	and	EcoRI	and	cloned	into	the	same	
sites	of	 inducible	expression	vector,	pcDNA4/TO/neo	
modified	by	us	as	follow:	neomycin	phosphotransferase	
gene	was	cut	from	the	pcDNA3	plasmid	(Invitrogen	Life	
Technologies,	USA)	and	ligated	in	the	pcDNA4/TO	(Invit-
rogen	Life	Technologies,	USA).	The	obtained	construct	
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pcDNA4/TO/neo	was	verified	by	the	restriction	analysis	
using	endonucleases	NruI	and	XhoI.	
The	 correctness	 of	 insert	 in	 abovementioned	
construct	carrying	hBD-2m	gene	was	verified	by	the	
DNA	sequencing	and	plasmids	were	purified	using	a	
standard	protocol	[15].
Transfection HEK293T cells.	 The	 resulting	
constructs	were	cotransfected	with	 the	 regulatory	
plasmid,	pcDNA6/TR	 (Invitrogen	Life	Technologies,	
USA),	which	contained	a	selective	marker	—	the	blas-
ticidin	S	deaminase	gene,	 into	HEK293T	cells	using	
FuGENE	6	Reagent	(Roche	Molecular	Biochemicals,	
USA)	according	to	the	 instructions	of	manufacturer.	
After	transfection	cells	were	selected	in	medium	with	
5	µg/ml	blasicidin	(Invitrogen	Life	Technologies,	USA)	
and	600	µg/ml	G418	(Gibco,	USA)	for	2	weeks.	Resis-
tant	cells	were	treated	with	tetracycline	to	derepress	
the	hybrid	CMV/TetO2	promoter	 in	pcDNA4/TO/neo	
and	to	induce	expression	of	hBD-2	mature	form.	
Expression of mature hBD2 mRNA.	After	24	h	
incubation	of	obtained	cell	 line	T-rex-HEK-hBD-2m 
with	tetracycline,	mRNA	was	isolated	and	the	level	of	
expression	of	hBD-2	was	analysed	by	RT-PCR	with	the	
use	of	abovementioned	primers.	
Immunocytochemical analysis of hBD�2 expres� 
sion. Cells were sedimented by centrifugation, and cell	 	 	 	 	 	 	
pellet	was	fixed	with	4% formaline for 4 h, washed with	 	 	 	 	 	 	
PBS	and	stored	in 70	 °	ethanol. Later the paraffin blocks	 	 	 	 	
were	prepared,	4	µm slides were cut and analysed im-	 	 	 	 	 	
munocytochemically	using	anti-hBD-2-MoAbs [16]	 	
at	the	dilution of 1 : 10 and 1 : 25. For the part of the	 	 	 	 	 	 	 	 	 	 	 	 	 	
samples,	renewal	of	antigenic	properties	using	Target	
Retrieval	Solution	(DAKO,	USA) according to protocol	 	 	 	
of	the	manufacturer	was	applied. To block nonspecific	 	 	 	
binding,	biotin-blocking	system(DAKO,USA)wasused.	 	 	 	 	
Anti-mouse	antibodies	labeled	with	biotin (Sigma,USA)	 	 	
were	used	at	the	dilution of 1 : 400�� Vectastain ABC Kit	 	 	 	 	 	 	 	
(Vecor	Lab.,	USA)withperoxidaseprobewasusedasthe	 	 	 	 	 	 	 	
third	coating. As negative control, 1%BSA (Dia�, Rus-	 	 	 	 	 	 	
sia) prepared on 0.02�phosphate buffer (��� 7.2) was	 	 	 	 	 	 	 	 	 	
used	instead	of	specific	antibodies. As positive control,	 	 	 	
gastric	tumor	tissue	samples	expressinghBD-2[16]were	 	 	 	
used.	Peroxidase conjugate was developed by 0.05%	 	 	 	 	 	
3’3’-diaminobenzidinetetrahydrochloride (Sigma,USA)	 	 	
solution	containing	0.01%	hydrogen peroxide. Nuclei	 	 	
were	counterstained	with	Mayer’s	hematoxyline.	
The	study	was	performed	using	microscope	Axio-
plan	(Zeiss,	Germany)	equipped	with	the	videocamera	
Sony	DXC-151AP,	EZ	Capture,	computer	Pentium	IV,	
and	program	for	analysis	of	images	(Media	Cybernetic,	
USA).	Ten	fields	of	view	were	studied	per	sample.
Colony formation analysis.	Analysis	of	colony	
forming	ability	of	the	cells	was	carried	out	by	routine	
technique	as	described	elsewhere	[17]	in	DMEM	me-
dium	supplemented	with	15%	FBS	and	0.4%	methylcel-
lulose	without/with	1	µg/ml	tetracycline.	The	cells	were	
dispensed	in	6-well	plates	(1	х	103	cells	per	1	ml	of	me-
dium)	and	incubated	in	СО2-incubator	for	14–16	days.	
The	colonies	were	visualized	using	staining	procedure	
with	0.2%	p-iodonitrotetrazolium	violet	dye.
RESULTS AND DISCUSSION
Generation	of	T-REX-HEK-hBD-2	cell	sublines.	For	
cloning	and	expression	of	hBD-2	gene	in	mammalian	
cells	two-vector	T-REx	system	was	choosed.	Such	sys-
tem	contains	expressing	vector	pcDNA4/TO	designed	
for	cloning	of	 the	gene	of	 interest,	and	pcDNA6/TR	
vector	coding	Tet	repressor.	Co-transfection	of	these	
two	vectors	allows	 to	perform	tetracycline-regulated	
expression	of	the	gene	of	interest	in	mammalian	cells.	
Plasmid	pcDNA4/TO	contains	hybrid	promoter	provid-
ing	high	 level	of	 tetracycline-regulated	expression	 in	
different	 types	of	cells.	Promoter	 is	composed	 from	
two	parts	—	early	promoter	of	human	cytomegalo-
virus	(CMV)	and	region	of	 two	 tetracycline	operators	
(TetII	O2).	For	selection	of	stable	cell	lines,	the	gene	of	
resistance	to	zeocin	is	introduced	in	this	plasmid.	Two	
TetII	O2	sequences	present	 the	 region	of	binding	of	
4	Tet	repressor	molecules	(two	Tet	homodimers).	Tet	
repressor	is	expressed	by	pcDNA6/TR	plasmid.	In	the	
absence	of	tetracycline	expression	of	the	cloned	gene	
is	suppressed	 through	 the	binding	of	Tet	 repressor	
homodimers	with	TetII	O2	sequences.	Addition	of	tet-
racycline	to	the	cells	derepresses	hybrid	CMV/	TetII	O2	
promoter	in	pcDNA4/TO	plasmid	via	its	binding	with	Tet	
repressor	and	allows	expression	of	the	cloned	gene.
T-REx	system	responded	to	all	our	requirements	—	
cloning	of	hBD-2	gene,	except	the	site	of	resistance	
to	zeocin	—	this	antibiotic	is	too	expensive	and	rare��	
that’s	why	we	decided	to	replace	it	by	another	selective	
marker	—	Neomycin:	 the	gene	of	zeocin	resistance	
has	been	removed	from	pcDNA4/TO	by	restriction	at	
NruI/XhoI	sites,	and	neomycin	gene	cut	from	the	plas-
mide	pcDNA3.1+	(Invitrogen,	USA)	was	inserted.	The	
generated	vector	was	named	pcDNA4/TO/neo.
After	this	151	bp	fragment	received	by	HindIII/EcoRI	
restriction	was	cloned	 into	pcDNA4neo	plasmid	by	
	HindIII/EcoRI	sites.	Selection	of	recombinant	clones	
was	performed	by	 restriction	 analysis	 allowed	 to	
choose	clone	pcDNA4/TO/neo/hBD2m,	containing	
the	sequence	coding	mature	hBD-2	molecule.
Next,	HEK293T	 cells	were	 cotransfected	with	
pcDNA6/TR	plasmid	and	pcDNA4/TO/neo/hBD2m	by	
standard	procedure.	Selection	of	clones	was	based	on	
blasticidin/G418	 resistance.	As	 the	positive	control,	
pcDNA4/TO/lacZ	vector	was	used.	Co-transfection	of	
pcDNA4/TO/lacZ	and	pcDNA6/TR	resulted	in	induction	
of	β-galactosidase	gene	upon	addition	of	tetracycline,	
and	may	be	registered	by	staining	using	X-Gal.
Expression of hBD�2 in T�REX�HEK�hBD�2 cell 
sublines. As	we	have	shown	earlier,	 the	highest	 level	
of	defensin	expression	in	engineered	cell	line	could	be	
achieved	in	20	h	after	induction	with	1	µg/ml	tetracycline.	
RT-PCR	analysis	has	demonstrated	 that	 the	highest	
level	of	 transcription	of	gene	coding	mature	molecule	
of	hBD-2	is	registered	in	cell	subline T-rex HEK-hBD2-	 	
m,	induced	with	1 µg/ml tetracycline, at lower level— in	 	 	 	 	 	 	 	
cell	lines T-rex-HEK-hBD2-m grown in the absence of	 	 	 	 	 	 	
antibiotic,	whilst	 in	parental	HEK293T	cells expression	 	
of	hBD-2	mRNA	wasn’t	registered	by	the	applied	tech-
nique	(Fig. 1). These data indicated that to some extent	 	 	 	 	 	 	 	 	
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the	tet-regulated	promoter	is	leaking	(the	most	possible	
explanation	is	that	there	are	trace	amounts	of	tetracycline	
in	the	components	of	culture	medium).	Unfortunately,	we	
were	unable	to	analyze	the	expression	of	defensin	mol-
ecules	using	Western	blot	analysis	because	anti-hBD-2	
MoAbs	generated	in	our	lab	earlier	[16]	fail	to	recognize	
native	antigen	in	this	assay.	For	this	reason	production	
of hBD-2 peptide in cell subline has been studied using	 	 	 	 	 	 	 	 	 	
immunocytochemical	approach	with	the	use	of	anti-hBD-
2-mAbs	(that	method	was	appropriate	for	detection	of	
hBD-2,	as	it	was	estimated	using	the	samples	of	human	
gastric	tumors	characterized	by	hyperexpression	of	hBD-
2	[16]	or	A431	cells	induced	by	EGF	as	a	positive	control	
(data	not	presented)). As one may see from Fig. 2, the	 	 	 	 	 	 	 	 	
distribution	of	cells	by	hBD-2	content	 looks as follow:	 	 	
parental	HEK293T	cells	<	T-rex	HEK-HBD2-m	Tetr-	<	
T-rex	HEK-HBD2-m	Tetr+.
Fig. 1. RT-PCR	analysis	of	hBD-2	expression.	� — DNA lad-	 	 	
der�� 1, 2—HEK293T cells without/with tetracycline incubation��	 	 	 	 	 	 	 	 	
3,	4	—	T-rex	HEK-hBD2m cells without induction with tetracy-	 	 	 	 	
cline�� and after induction with tetracycline respectively	 	 	 	 	 	
Expression of hBD�2 leads to altered cell growth 
patterns and ability to form colonies in methylcel�
lulose clonal culture. The	study	of	growth	patterns	of	
cell	subline	T-rex	HEK-hBD2-m	compared	to	these	of	
parental	��ЕК293Т	cells	was	performed	by	methods	of	
light	microscopy	and	colony	formation	assay.	We	have	
registered	 the	phenomenon	that	T-rex	HEK-hBD2-m	
cells	(contrary	to	parental	strain)	acquire	ability	for	pro-
longed	growth	in	culture	(up	to	148	h)	even	in	the	absence	
of	FBS,	i.	e.	on	“starving”	medium	(upon	such	conditions,	
��ЕК293T	cells	die	in	48–62	h).	Using	direct	cell	counting,	
it	was	found	out	that	the	number	of	T-rex	HEK-hBD2-m	
cells	cultivated	 in	 the	presence	of	 tetracycline	 in	 the	
“starving”	medium,	increased	nearly	1.7	fold	during	the	
1st	day,	and	nearly	3-fold	—	till	 the	end	of	 the	2nd	day	
versus	1.5-	and	2-fold	increase	in	T-rex HEK-hBD2-m	 	
cultivated	without	tetracycline	(the number of parental	 	 	 	
cells	did	not	alter	significantly)	(Table).	
Table. T�e n�mber o� cells eval�a�ed b� direc� cell co�n�in�
Cell line Cell n�mber (10
6 cells) (mean sq�are devia�ion)
Ini�ial 18 � 26 � 52 �
HEK293T Te�– 0.50 1.0 ± 0.25 0.40 ± 0.1* 0.50 ± 0.13*
HEK293T Te�+ 0.50 0.52 ± 0.16* 0.34 ± 0.01* 0.40 ± 0.05*
T-rex HEK-���2-m Te�– 0.30 0.52 ± 0.09* 0.50 ± 0.12* 0.65 ± 0.05*
T-rex HEK-���2-m Te�+ 0.30 0.56 ± 0.06* 0.60 ± 0.22 0.95 ± 0.05*
*S�a�is�icall� si�ni�ican�, p < 0.05.
The	growth-stimulatory	patterns	of	hBD-2	expres-
sion	 in	 the	cells	are	 in	agreement	with	our	previous	
results	obtained	with	the	use	of	recombinant	hBD-2	
expressed	in	bacterial	cells	[10]	that	showed	the	pro-
moting	effect	of	rec-hBD-2	at	the	concentrations	of	
0.1–2	µg/ml	on	proliferation	and	viability	of	eukaryotic	
cells	 in vitro.	Yet	we	can’t	evaluate	the	exact	level	of	
hBD-2	production	per	cell	in	generated	cell	sublines,	
but	one	may	speculate	that	according	to	the	observed	
biologic	effect,	 its	production	may	be	close	 to	 the	
mentioned	above	concentration	range.
Another	 specific	pattern	 that	has	been	noticed	
is	 the	phenomenon	of	deprivation	of	ability	 to	 form	
confluent	monolayer	by	��ЕК/hBD-2m	cells	cultured	
in	the	presence	of	1	µg/ml	tetracycline	(Fig.	3,	a–d).	
Whilst	parental	HEK293	cells	are	growing	 in	 typical	
monolayer,	where	the	cells	possess	flattened	or	spread	
morphology,	tetracycline-induced	��ЕК/hBD-2m	cells	
seem	to	loose	this	property	forming	multilayer	clusters	
and	possessing	mostly	rounded	morphology.	It	looks	
like	that	normal	cell-to-cell	contacts	are	disturbed,	as	
Fig. 2.  Immunocytochemical	analysis	of	hBD-2	expression	in	wild type��ЕКcells (	 	 	 	 a),	T-rex	HEK-hBD2mTetr	 _	(b),	T-rex	HEK-hBD2m	
Tetr+(c).	x 100	
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well	as	adhesion	properties	of	the	cells.	We	speculate	
that	such	effect	may	be	explained	in	part	by	possible	
alteration	of	cell	adherence	in	hBD-2-producing	cells.	
The	morphological	 features	of	 tetracycline-induced	
T-rex��ЕК-hBD-2m	cells	closely	 resembled	 these	of	
HEK293T	cells	 expressing	chymeric	 constructs	of	
ADAM9	(a	desintegrin	and	metalloprotease	9),	mol-
ecule	 interacting	with	β-integrins	 in	 renal	cells	and	
affecting	their	adherence	properties	[19].	There	are	
some	 reports	evidencing	 the	possible	 link	between	
alpha-defensins	and	adhesion	molecules.	It	has	been	
shown	 that	alpha-defensins	may	specifically	 inhibit	
alpha5beta1-integrin-dependent	migration	of	bovine	
retinal	endothelial	cells	 to	FN	 in vitro	 [20].	Another	
research	demonstrated	 that	human	neutrophil	pep-
tides	 (HNPs)	promote	 the	binding	of	 fibronectin	 to	
alpha5beta1	integrin	and	may	affect	endothelial	cell	
adhesion	and	migration	in	FN-dependent	manner	[21].	
So,	there	are	some	grounds	to	speculate	that	specific	
morphological	and	growth	patterns	of	T-rexHEK-hBD-
2m	cells	could	be	related	to	hBD-2-dependent	altera-
tion	of	adhesive	properties	of	the	cells.	
Finally	we	have	performed	colony-formation	as-
say	using	0.4%	methylcellulose	without/with	1	µg/ml	
tetracycline,	 and	 found	out	 that	 after	 2	weeks	 of	
growth	HEK293T	cells	formed	multiple	colonies,	but	
T-rexHEK-hBD-2m	cells	seeded	at	the	same	density	
of	1	x	103	cells/ml	did	not	and	form	only	single	colonies	
in	 tetracycline	 free	medium.	So,	one	may	conclude	
that	expression	of	hBD-2	in	T-rexHEK-hBD-2m	cells	
may	result	in	the	loss	of	the	pattern	of	malignization	
(namely,	ability	to	form	colonies	in	semiliquid	medium)	
characteristic	for	parental	HEK293T	cells.
In	conclusion,	we	may	assume	that	stable	cell	subline	
T-rexHEK-hBD-2m	expressing	mature	hBD-2	molecule	
in	tetracycline-dependent	manner	has	been	created��	
whilst	wild	type	cells	do	not	express	and	produce	hBD-2,	
T-rexHEK-hBD-2	cells	express	hBD-2	upon	incubation	
with	1	µM	tetracycline	in	incubation	medium,	as	it	has	
been	shown	by	RT-PCR	and	 immunocytochemical	
analysis.	Our	data	have	demonstrated	that	prolonged	
expression	(>	48	h)	of	endogeneous	hBD-2	resulted	in	
a	number	of	biological	effects:	hBD-2-producing	cells	
lost	normal	adhesive	properties	as	well	as	the	ability	to	
form	colonies	 in	agar,	characteristic	 to	parental	HEK	
cells,	but	acquire	some	features	favoring	the	acceler-
ated	growth	and	survival.	Our	preliminary	data	allow	to	
suppose	that	some	signal	cascades	in	these	cells	(in	
particular,	PDK1-Akt,	and	p70S6	kinase)	are	involved	
in	mediating	abovementioned	events��	the	research	of	
these	enzymes	and	expression	of	adhesion	molecules	
is	currently	under	study.
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ИЗМЕНЕНИЕ ФЕНОТИПА И ОСОБЕННОСТЕЙ РОСТА 
В КУЛЬТУРЕ ЛИНИИ ЭМБРИОНАЛЬНЫХ КЛЕТОК ПОЧКИ 
ПРИ РЕГУЛИРУЕМОЙ ЭКСПРЕССИИ БЕТА-ДЕФЕНСИНА-2 
Цель: создать линию клеток с регулируемой экспрессией бета-дефенсина-2 человека (hBD-2) и проанализировать влияние 
экспрессии этого пептида на особенности фенотипа и рост клеток. Материалы и методы: клеточная сублиния T-rex HEK- 
hBD2-m, экспрессирую�ая биологически активную зрелую форму hBD-2 при индук�ии клеток тетра�иклином, получена            
путем клонирования на основе эмбриональных клеток почки человека линии HEK293T. Морфологические особенности, 
характеристики роста и показатели колониеобразования в полужидкой среде исследовали стандартными методами. Результаты: 
с помо�ью методов РТ-ПЦР и иммуно�итохимии показано, что сублиния клеток T-rex HEK-HBD2-m экспрессирует hBD2    
в присутствии 1 µг/мл тетра�иклина в среде инкуба�ии. Продолжительная экспрессия hBD-2 приводила к тому, что клетки 
утрачивали способность образовывать монослой при культивировании in vitro и образовывать колонии в полужидкой среде, но 
характеризовались более высокой скоростью роста и способностью к более продолжительному выживанию в бессывороточной 
среде, чем исходная линия клеток HEK293T. Выводы: экспрессия hBD-2 в сублинии клеток T-rex HEK-HBD2-m cell   
обусловливает спе�ифические биологические эфеекты, способствую�ие выживанию клеток.
Ключевые слова: бета-дефенсин-2 человека, регулируемая экспрессия, колониеобразование, клетки линии HEK293.
